Alterity Therapeutics Lim... (ATHE)
NASDAQ: ATHE
· Real-Time Price · USD
5.17
-0.06 (-1.15%)
At close: Aug 15, 2025, 3:59 PM
5.20
0.58%
After-hours: Aug 15, 2025, 06:47 PM EDT
Alterity Therapeutics Cash Flow Statement
Financials in AUD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 |
Net Income | -19.79M | -16.2M | -12.62M | n/a | n/a | -8.03M | -14.3M | -20.88M | -20.88M | -12.85M | -15.15M | -16.38M | -22.02M |
Depreciation & Amortization | 36.3K | 36.3K | n/a | n/a | n/a | 50K | 72.67K | 104.21K | 104.21K | 54.21K | 67.17K | 90.84K | 148.06K |
Stock-Based Compensation | 1.41M | 845.46K | 284.83K | n/a | n/a | 627.22K | 1.26M | 2.13M | 2.13M | 1.51M | 2.45M | 1.57M | 1.57M |
Other Working Capital | 1.29M | 2.3M | 1.2M | n/a | n/a | 866.75K | 898.8K | 473.46K | 473.46K | -393.29K | -133.74K | 84.5K | 360.24K |
Other Non-Cash Items | 748.03K | -3.6M | -3.41M | -14.61M | -14.61M | -6.85M | -11.27M | -2.38M | -2.38M | -15.64M | -6.92M | -5.83M | 4.03M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 1.05M | 7.29M | 5M | 5M | 3.95M | -2.12M | 1.33M | 1.33M |
Change in Working Capital | 1.13M | 2.13M | 3.14M | n/a | n/a | -2.12M | 1.42M | -357.09K | -357.09K | 1.76M | -3.15M | -312.27K | 2.82M |
Operating Cash Flow | -16.47M | -16.79M | -12.61M | -14.61M | -14.61M | -15.27M | -15.53M | -14.09M | -14.09M | -18.93M | -26M | -24.18M | -16.76M |
Capital Expenditures | 278.00 | -5.44K | -9.44K | -12.16K | -17.16K | -16.31K | -101.31K | -101.44K | -96.44K | -102.03K | -15.52K | -22.21K | -19.24K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -1K | n/a | n/a | -28.15K | -28.15K | -29.15K | -29.15K | 2.56K | 2.56K | 2.56K | 2.56K | n/a | n/a |
Investing Cash Flow | -722 | -1.72K | -5.72K | -31.58K | -36.58K | -40.46K | -125.46K | -101.44K | -96.44K | -102.03K | -15.52K | -22.21K | -19.24K |
Debt Repayment | -10.37K | -10.37K | -10.37K | -32.15K | -32.15K | -59.92K | -94.44K | -86.04K | -86.04K | -116.56K | -106.29K | -82.54K | -69.57K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -226.54K | -751.86K | -918.02K | -832.44K | -216.44K | -141.41K | -118.94K | -377.75K | -320.75K | -2.73M | 31.45M | 31.22M | 33.66M |
Financial Cash Flow | 8.78M | 9.38M | 9.22M | 9.19M | 1.07M | -13.66K | -25.66K | -35.9K | -160.9K | 36.6M | 70.79M | 74.12M | 37.47M |
Net Cash Flow | 1.55M | 1.91M | 2.85M | -22.81M | -32.2M | -34.32M | -33.08M | -12.08M | -8.67M | 25.92M | 49.6M | 52.73M | 26.14M |
Free Cash Flow | -19.05M | -19.73M | -15.01M | -13.1M | -14.43M | -14.73M | -15.62M | -18.09M | -14.18M | -26.35M | -33.34M | -31.52M | -16.78M |